Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: LYMPHOMA, LARGE B-CELL, DIFFUSE - MORTALITY , . Treffer: 7

2016

Troppan, KT; Melchardt, T; Wenzl, K; Schlick, K; Deutsch, A; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Tränkenschuh, W; Greil, R; Neumeister, P; Egle, A; Pichler, M The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
J Clin Pathol. 2016; 69(4):326-330
Web of Science PubMed FullText FullText_MUG

 

2015

Massone, C; Fink-Puches, R; Wolf, I; Zalaudek, I; Cerroni, L Atypical clinicopathologic presentation of primary cutaneous diffuse large B-cell lymphoma, leg type.
J Am Acad Dermatol. 2015; 72(6):1016-1020
Web of Science PubMed FullText FullText_MUG

 

Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Schlick, K; Huemer, F; Deutsch, A; Neumeister, P; Greil, R; Pichler, M; Egle, A Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI.
J Natl Compr Canc Netw. 2015; 13(12):1501-1508 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Troppan, KT; Melchardt, T; Deutsch, A; Schlick, K; Stojakovic, T; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Egle, A; Pichler, M The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Eur J Haematol. 2015; 95(6):538-544
Web of Science PubMed FullText FullText_MUG

 

2014

Mian, M; Wasle, I; Gamerith, G; Mondello, P; Melchardt, T; Jäger, T; Linkesch, W; Fiegl, M R-CHOP versus R-COMP: are they really equally effective?
Clin Oncol (R Coll Radiol). 2014; 26(10):648-652
Web of Science PubMed FullText FullText_MUG

 

2012

Felcht, M; Heck, M; Weiss, C; Becker, JC; Dippel, E; Muller, CSL; Nashan, D; Sachse, MM; Nicolay, JP; Booken, N; Goerdt, S; Klemke, CD; Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells.
BRIT J DERMATOL. 2012; 167(2): 348-358.
Web of Science PubMed FullText FullText_MUG

 

2004

Simonitsch-Klupp, I; Hauser, I; Ott, G; Drach, J; Ackermann, J; Kaufmann, J; Weltermann, A; Greinix, HT; Skrabs, C; Dittrich, C; Lutz, D; Pötter, R; Mannhalter, C; Lechner, K; Chott, A; Jaeger, U Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome.
Leukemia. 2004; 18(1): 146-155. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum